390
Views
8
CrossRef citations to date
0
Altmetric
Review

War on terror cells: killing the host that harbours ‘superbugs’ is an infection control strategy in our fight against infectious diseases

&

References

  • Khan NA. Acanthamoeba: biology and pathogenesis. Norfolk: Caister Academic Press; 2009.
  • Siddiqui R, Khan NA. Infection control strategy by killing drug-resistant bacteria. Pathog Glob Health. 2013;107:215–6.
  • Nordmann P, Naas T, Fortineau N, Poirel L. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. Curr Opin Microbiol. 2007;10:436–40.
  • Alanis AJ. Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res. 2005;36:697–705.
  • Blondeau J. Gram-negative superbugs: inappropriate antimicrobial therapy and mortality. Expert Rev Clin Pharmacol. 2013;6:347–9.
  • CDC. Antibiotic resistance threats in the United States, 2013. Atlanta (GA): CDC; 2013. Available from: http://www.cdc.gov/drugresistance/threat-report-2013/ (accessed 22 May 2013).
  • Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:5046–54.
  • Oberoi L, Singh N, Sharma P, Aggarwal A. ESBL, MBL and Ampc β lactamases producing superbugs — havoc in the intensive care units of Punjab India. J Clin Diagn Res. 2013;7:70–3.
  • Trivedi TH, Sabnis GR. Superbugs in ICU: is there any hope for solution? J Assoc Physicians India. 2009;57:623–5.
  • Appelbaum PC. 2012 and beyond: potential for the start of a second pre-antibiotic era? J Antimicrob Chemother. 2012;67:2062–8.
  • Barbosa TM, Levy SB. The impact of antibiotic use on resistance development and persistence. Drug Resist Updat. 2000;3:303–11.
  • Marshall BM, Levy SB. Food Animals and Antimicrobials: Impacts on Human Health. Clin Microbiol Rev. 2011;24:718–33.
  • Levy SB. The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother. 2002;49:25–30.
  • Klein E, Smith DL, Laxminarayan R. Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999–2006. Emerg Infect Dis. 2009;15:1925–30.
  • Centers for Disease Control and Prevention. Atlanta (GA): CDC. Available from: http://www.cdc.gov/ (accessed 6 June 2013).
  • McCormick D, Thorn S, Milne D, Evans C, Stevenson J, Llano M, et al.; Incident Management Team. Public health response to an outbreak of Legionnaires’ disease in Edinburgh, United Kingdom, June 2012. Euro Surveill. 2012;17(28):pii:20216.
  • WHO. Use of antimicrobials outside human medicine and resultant antimicrobial resistance in humans. Geneva: WHO; 2002. Available from: http://www.who.int/mediacentre/factsheets/fs268/en/index.html (accessed 6 June 2013).
  • Snitkin ES, Zelazny AM, Thomas PJ, Stock F; NISC Comparative Sequencing Program Group, Henderson DK, Palmore TN, Segre JA. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med. 2012;4:148.
  • Levy SB. The challenge of antibiotic resistance. Sci Am. 1998;278:46–53.
  • Madeo M. Cleaning the hospital environment — a focus on Difficil-S. Br J Nurs. 2011;20:688,690–93.
  • Eckstein BC, Adams DA, Eckstein EC, Rao A, Sethi AK, Yadavalli GK, et al. Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect Dis. 2007;7:61.
  • Coulon C, Collignon A, McDonnell G, Thomas V. Resistance of Acanthamoeba cysts to disinfection treatments used in health care settings. J Clin Microbiol. 2010;48:2689–97.
  • Briancesco R, Veschetti E, Ottaviani M, Bonadonna L. Peracetic acid and sodium hypochlorite effectiveness in reducing resistant stages of microorganisms. Cent Eur J Public Health. 2005;13:159–62.
  • Rowbotham TJ. Preliminary report on the pathogenicity of Legionella pneumophila for freshwater and soil amoebae. J Clin Pathol. 1980;33:1179–83.
  • Lloyd D, Turner NA, Khunkitti W, Hann AC, Furr JR, Russell AD. Encystation in Acanthamoeba castellanii: development of biocide resistance. J Eukaryot Microbiol. 2001;48:11–6.
  • Turner NA, Russell AD, Furr JR, Lloyd D. Emergence of resistance to biocides during differentiation of Acanthamoeba castellanii. J Antimicrob Chemother. 2000;46:27–34.
  • Turner NA, Russell AD, Furr JR, Lloyd D. Resistance, biguanide sorption and biguanide-induced pentose leakage during encystment of Acanthamoeba castellanii. J Appl Microbiol. 2004;96:1287–95.
  • Connell C, Rutter A, Hill B, Suller M, Lloyd D. Encystation of Acanthamoeba castellanii: dye uptake for assessment by flow cytometry and confocal laser scanning microscopy. J Appl Microbiol. 2001;90:706–12.
  • Martinez AJ, Visvesvara GS. Free-living, amphizoic and opportunistic amebas. Brain Pathol. 1997;7:583–98.
  • Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev. 2003;16:273–307.
  • Khan NA. Acanthamoeba: biology and increasing importance in human health. FEMS Microbiol Rev. 2006;30:564–95.
  • Visvesvara GS, Moura H, Schuster FL. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol. 2007;50:1–26.
  • La Scola B, Audic S, Robert C, Jungang L, de Lamballerie X, Drancourt M, et al. A giant virus in amoebae. Science. 2003;299:2033.
  • Greub G, Raoult D. Microorganisms resistant to free-living amoebae. Clin Microbiol Rev. 2004;17:413–33.
  • Mazur T, Hadaś E, Iwanicka I. The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates. Trop Med Parasitol. 1995;46:106–8.
  • Sriram R, Shoff M, Booton G, Fuerst P, Visvesvara GS. Survival of Acanthamoeba cysts after desiccation for more than 20 years. J Clin Microbiol. 2008;46:4045–8.
  • Rodriguez-Zaragoza S, Magana-Becerra A. Prevalence of pathogenic Acanthamoeba (Protozoa: Amoebidae) in the atmosphere of the city of San Luis Potosi, Mexico. Toxicol Ind Health. 1997;13:519–26.
  • Borazjani RN, Kilvington S. Efficacy of multipurpose solutions against Acanthamoeba species. Cont Lens Anterior Eye. 2005;28:169–75.
  • Buck SL, Rosenthal RA, Schlech BA. Methods used to evaluate the effectiveness of contact lens care solutions and other compounds against Acanthamoeba: a review of the literature. CLAO J. 2000;26:72–84.
  • Kobayashi T, Gibbon L, Mito T, Shiraishi A, Uno T, Ohashi Y. Efficacy of commercial soft contact lens disinfectant solutions against Acanthamoeba. Jpn J Ophthalmol. 2011;55:547–7.
  • Johnston SP, Sriram R, Qvarnstrom Y, Roy S, Verani J, Yoder J, et al. Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solution. J Clin Microbiol. 2009;47:2040–5.
  • Shoff ME, Joslin CE, Tu EY, Kubatko L, Fuerst PA. Efficacy of contact lens systems against recent clinical and tap water Acanthamoeba isolates. Cornea. 2008;27:713–9.
  • Verani JR, Lorick SA, Yoder JS, Beach MJ, Braden CR, Roberts JM, et al.; Acanthamoeba Keratitis Investigation Team. National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. Emerg Infect Dis. 2009;15:1236–42.
  • Doan L, Forrest H, Fakis A, Craig J, Claxton L, Khare M. Clinical and cost effectiveness of eight disinfection methods for terminal disinfection of hospital isolation rooms contaminated with Clostridium difficile 027. J Hosp Infect. 2012;82:114–21.
  • Passaretti CL, Otter JA, Reich NG, Myers J, Shepard J, Ross T, et al. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis. 2013;56:27–35.
  • Zoutman D, Shannon M, Mandel A. Effectiveness of a novel ozone-based system for the rapid high-level disinfection of health care spaces and surfaces. Am J Infect Control. 2011;39:873–9.
  • Gatti S, Cevini C, Bruno A, Penso G, Rama P, Scaglia M. In vitro effectiveness of povidone-iodine on Acanthamoeba isolates from human cornea. Antimicrob Agents Chemother. 1998;42:2232–4.
  • Huws SA, Smith AW, Enright MC, Wood PJ, Brown MR. Amoebae promote persistence of epidemic strains of MRSA. Environ Microbiol. 2006;8:1130–3.
  • Tomlinson G, Jones EA. Isolation of cellulose from the cyst wall of a soil amoeba. Biochim Biophys Acta. 1962;63:194–200.
  • Neff RJ, Neff RH. The biochemistry of amoebic encystment. Symp Soc Exp Biol. 1969;23:51–81.
  • Hirukawa Y, Nakato H, Izumi S, Tsuruhara T, Tomino S. Structure and expression of a cyst specific protein of Acanthamoeba castellanii. Biochim Biophys Acta. 1998;1398:47–56.
  • Dudley R, Jarroll EL, Khan NA. Carbohydrate analysis of Acanthamoeba castellanii. Exp Parasitol. 2009;122:338–343.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.